Evidence map›Paper›PMID 37638134›Full record

ArticleF1000Research2022

Case Report: High-grade anterior prostate cancer previously undetected by transrectal biopsy, diagnosed with MRI-US fusion transperineal robotic prostate biopsy.

Andrian Harsanto, Adistra Imam Satjakoesoemah, Rochani Sumardi, Sahat B R E Matondang, Meilania Saraswati

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in F1000Research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Andrian HarsantoDepartment of Urology, Abdi Waluyo Hospital, Central Jakarta, DKI Jakarta, 10350, Indonesia.ORCID https://orcid.org/0000-0002-5509-2665
Adistra Imam SatjakoesoemahDepartment of Urology, Abdi Waluyo Hospital, Central Jakarta, DKI Jakarta, 10350, Indonesia.ORCID https://orcid.org/0000-0003-4209-7077
Rochani SumardiDepartment of Urology, Abdi Waluyo Hospital, Central Jakarta, DKI Jakarta, 10350, Indonesia.
Sahat B R E MatondangDepartment of Radiology, Abdi Waluyo Hospital, Central Jakarta, DKI Jakarta, 10350, Indonesia.ORCID https://orcid.org/0000-0002-7886-404X
Meilania SaraswatiDepartment of Anatomical Pathology, Dr. Cipto Mangunkusumo Hospital, Central Jakarta, DKI Jakarta, 10430, Indonesia.
Rumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo · ID

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Seventy percent of anterior prostate cancer cases are diagnosed during rebiopsy. MRI-US fusion transperineal robotic prostate biopsy is an emerging diagnostic method and might be an effective one in diagnosing prostate cancers in difficult sites such as the anterior zone. We report a case of a high grade anterior prostate cancer previously undetected by transrectal biopsy, diagnosed with MRI-US fusion transperineal robotic prostate biopsy. This case report suggests that MRI-US fusion transperineal robotic prostate biopsy might be valuable in diagnosing prostate cancer especially in difficult sites - the anterior region in this case - and might be an imperative diagnostic method in suspicious cases with prior negative biopsy.

Indexed as

anterior prostate cancerrobotic prostate biopsytargeted biopsy

Identifiers

PMID37638134
PMCPMC10450259
OpenAlexW4214509668

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.